| Visiting Nurse Comm Health Inc | |
| 37 Broadway Steet, Arlington, Massachusetts 2474 | |
| (781) 643-6090 | |
| Not Available |
| Name | Visiting Nurse Comm Health Inc |
|---|---|
| Location | 37 Broadway Steet, Arlington, Massachusetts |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 227005 |
| Ownership Type | Voluntary Non-profit - Private |
| Service Area Zip Codes |
| NPI Number | 1285659052 |
| Organization Name | VISITING NURSE AND COMMUNITY HEALTH, INC |
| Address | 37 Broadway, Arlington, MA 02474 |
| Phone Number | 781-643-6090 |
News Archive
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects.
› Verified 7 days ago
| NPI Number | 1972508000 |
| Organization Name | MEDFORD VISITING NURSING ASSOCIATION |
| Doing Business As | GREATER MEDFORD VISITING NURSING ASSOCIATION |
| Address | 37 Broadway Ste 2, Arlington, MA 02474 |
| Phone Number | 781-643-6090 |
News Archive
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects.
› Verified 7 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects.
› Verified 7 days ago
News Archive
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects.
› Verified 7 days ago
Visiting Nurse Comm Health Inc Location: 37 Broadway Steet, Arlington, Massachusetts 2474 Ratings: NA Phone: (781) 643-6090 | |
Visiting Nurse And Community Care Location: 37 Broadway, Suite #2, Arlington, Massachusetts 2474 Ratings: Phone: (781) 396-2633 |